Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.

被引：0
|
作者：
Ganschow, R. [1 ]
Fischer, L. [1 ]
Ericzon, B. [1 ]
Dhawan, A. [1 ]
D'Alessandro, A. [1 ]
Goss, J. [1 ]
Sips, C. [1 ]
Balfour, A. [1 ]
Junge, G. [1 ]
机构：
[1] H2305 Study Grp, Hamburg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B1060
引用
收藏
页码：719 / 719
页数：1
相关论文
共 50 条
  • [1] Everolimus With Reduced Exposure to a Calcineurin Inhibitor in Pediatric Liver Transplant Recipients: Baseline Data From the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    TRANSPLANTATION, 2014, 98 : 719 - 719
  • [2] Everolimus in Combination With Reduced Calcineurin Inhibitor in Paediatric Liver Transplant Recipients: Baseline Data from the H2305 Study.
    Ganschow, R.
    Fischer, L.
    Ericzon, B. -G.
    Dhawan, A.
    D'Alessandro, A.
    Goss, J.
    Sips, C.
    Balfour, A.
    Junge, G.
    LIVER TRANSPLANTATION, 2014, 20 : S281 - S282
  • [3] Everolimus with low-dose calcineurin inhibitor in pediatric liver transplant recipients: 12-month results of the H2305 study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Aguilar, Jose A.
    Ng, Jennifer
    Lopez, Patricia M.
    HEPATOLOGY, 2016, 64 : 493A - 493A
  • [4] LINEAR GROWTH AND SEXUAL MATURATION WITH EVEROLIMUS PLUS REDUCED CALCINEURIN INHIBITOR-BASED REGIMEN IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS: 12-MONTH RESULTS FROM H2305 STUDY.
    Briem-Richter, A.
    Brinkert, F.
    Grabhorn, E.
    Yap, J. K.
    Rasmussen, A.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 13 - 13
  • [5] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
    Weymann, A.
    Ganschow, R.
    Ericzon, B.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
  • [6] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED EXPOSURE TACROLIMUS OR CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION-24-MONTH RESULTS FROM H2305 STUDY.
    Ganschow, R.
    Ericzon, B. -G.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 13 - 13
  • [7] Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [8] Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study.
    Chadban, S.
    Mulgaonkar, S.
    Pascual, J.
    Tedesco, H.
    Berger, S.
    Qazi, Y.
    Legendre, C.
    Basic-Jukic, N.
    Bernhardt, P.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 475 - 475
  • [9] DESIGN OF H2305: A PROSPECTIVE STUDY EVALUATING EVEROLIMUS IN PAEDIATRIC LIVER TRANSPLANTATION
    Ganschow, Rainer
    Fischer, Lutz
    Torre, Giuliano
    Langer, Robert
    Ericzon, Bo-Goran
    Brunati, Andrea
    Sips, Carole
    Balfour, Alison
    Junge, Guido
    TRANSPLANT INTERNATIONAL, 2013, 26 : 329 - 330
  • [10] Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor
    Brandhorst, Gunnar
    Tenderich, Gero
    Zittermann, Armin
    Oezpeker, Cenk
    Koerfer, Reiner
    Oellerich, Michael
    Armstrong, Victor William
    THERAPEUTIC DRUG MONITORING, 2008, 30 (01) : 113 - 116
12345